Earnings Call for Q4FY22 of J B Chemicals & Pharmaceuticals
Conference Call with J B Chemicals & Pharmaceuticals Management and Analysts on Q4FY22 Performance and Outlook. Listen to the full earnings transcript.27-05-2022
27-05-2022
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper cutting of extract of consolidated financial results for quarter and year ended on March 31, 202227-05-2022
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor presentation on financial results for the quarter and year ended on March 31, 2022.27-05-2022
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press release the Company on audited consolidated financial results for the quarter and year ended on March 31, 2022.26-05-2022
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Corporate Action-Board approves Dividend
Recommendation of final dividend of Rs. 8 per share of FV Rs. 2 (400%) for FY 2021-22.26-05-2022
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors
1. Audited standalone financial results for the year ended on March 31, 2022 accompanied by Auditors' Report. 2. Audited consolidated financial results for the year ended on March 31, 2022 accompanied by Auditors' Report. 3. Declaration of Unmodified opinion26-05-2022
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Investors/Analysts Meet with management- May 27, 2022 at 3.30 p.m. IST in relation to business performance for Q4 & FY22 and other strategic imperatives.20-05-2022
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the financial year ended on March 31, 2022.13-05-2022
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Board to consider FY22 results & Final Dividend on May 26, 2022
JB Chemicals & Pharmaceuticals Ltd has informed BSE that meeting of the Board of Director of the Company will be held on May 26, 2022, inter alia, to consider and approve:1. Audited Financial Statements/annual finnacial results for the financial year ended March 31, 2022; and 2. Recommendation of final dividend, if any, for financial year 2021-22.11-05-2022